Related Experiment Videos
Three haplotypes associated with CYP2A6 phenotypes in Caucasians
Michael Haberl1, Birgit Anwald, Kathrin Klein
1EPIDAUROS Biotechnologie AG, Bernried, Germany. michael.haberl@epidauros.com
Pharmacogenetics and Genomics
|July 26, 2005
Summary
Genetic variants in the cytochrome P450 2A6 (CYP2A6) enzyme significantly impact its activity. Specific CYP2A6 alleles, including *1A-like, *9B, and *12B, are major determinants of CYP2A6 phenotype variation in Caucasians.
Area of Science:
- Pharmacogenomics
- Enzyme kinetics
- Molecular genetics
Background:
- The cytochrome P450 2A6 (CYP2A6) enzyme plays a crucial role in metabolizing numerous xenobiotics.
- Understanding genetic variations in CYP2A6 is vital for predicting drug response and toxicity.
Purpose of the Study:
- To identify genetic variants and major CYP2A6 haplotypes associated with phenotypic variation.
- To correlate CYP2A6 mRNA, protein levels, and enzyme activity.
Main Methods:
- Analysis of CYP2A6 mRNA, protein levels, and enzyme activity in Caucasian liver samples.
- DNA sequencing and genotyping to determine CYP2A6 haplotypes across diverse populations.
- Statistical analysis to associate haplotypes with observed phenotypes.
Main Results:
- Ninety-five distinct CYP2A6 polymorphisms were identified, with 49 being novel.
- Caucasian variants formed 33 haplotypes, categorized into four clades.
- CYP2A6*9B and CYP2A6*12B alleles were linked to reduced CYP2A6 expression; a CYP2A6*1A-like haplotype showed decreased expression and activity.
Conclusions:
- CYP2A6*1A-like, *9B, and *12B alleles are significant genetic determinants of CYP2A6 phenotype variation in Caucasians.
- These findings contribute to understanding inter-individual differences in drug metabolism and response.